ANI Pharmaceuticals Inc. Company Profile
NASDAQ: ANIPHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
ANI Pharmaceuticals at a glance
ANI Pharmaceuticals Inc. (NASDAQ: ANIP) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Baudette, MN. ANI Pharmaceuticals is led by Mr. Nikhil Lalwani and employs about 970 people. At a market capitalization of $1.65 billion, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0001023024, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does ANI Pharmaceuticals do?
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. The company serves its products to national wholesalers, specialty pharmacies, retail pharmacy chains, distributors, mail order houses, group purchasing organizations, and hospitals and healthcare providers. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
Business description based on the company's public filings.
Company information
- Legal name
- ANI Pharmaceuticals Inc.
- Ticker
- NASDAQ: ANIP
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Mr. Nikhil Lalwani
- Employees
- 970
- Headquarters
- 210 Main Street West, Baudette, MN, United States
- Phone
- 218 634 3500
- Website
- anipharmaceuticals.com
- Market cap
- $1.65B
- SEC CIK
- 0001023024
- Latest annual report
- 10-K · Feb 27, 2026
Companies similar to ANI Pharmaceuticals
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| OCULOcular Therapeutix Inc. | 7.51 | +3.87% | $1.65B | vs ANIP |
| ZBIOZenas BioPharma Inc. | 26.24 | -6.88% | $1.71B | vs ANIP |
| CMPSCOMPASS Pathways Plc American Depository Shares | 11.47 | -1.88% | $1.59B | vs ANIP |
| BRVEBraveheart Bio Inc. | 19.09 | +2.74% | $1.72B | vs ANIP |
| SEPNSepterna Inc. | 36.90 | +2.50% | $1.72B | vs ANIP |
| NUVBNuvation Bio Inc. Class A | 4.95 | +1.85% | $1.74B | vs ANIP |
| QUREuniQure N.V. | 22.54 | -2.59% | $1.56B | vs ANIP |
| STOKStoke Therapeutics Inc. | 23.95 | -1.40% | $1.55B | vs ANIP |